In immune and cancer cells, the Toll-like receptor (TLR)-mediated signaling pathway is a well-known mechanism that upregulates PD-L1 [67] through increasing NF-ƙB activation, which in turn leads to PD-L1 upregulation [105]. The gene discussed is CD274; the disease is cancer.